IL91639A0 - Method for determining preeclampsia,pregnancy induced hypertension or eclampsia,a reagent and kit for use therewith - Google Patents

Method for determining preeclampsia,pregnancy induced hypertension or eclampsia,a reagent and kit for use therewith

Info

Publication number
IL91639A0
IL91639A0 IL91639A IL9163989A IL91639A0 IL 91639 A0 IL91639 A0 IL 91639A0 IL 91639 A IL91639 A IL 91639A IL 9163989 A IL9163989 A IL 9163989A IL 91639 A0 IL91639 A0 IL 91639A0
Authority
IL
Israel
Prior art keywords
eclampsia
kit
reagent
induced hypertension
use therewith
Prior art date
Application number
IL91639A
Other languages
English (en)
Original Assignee
Aspen Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aspen Diagnostics Corp filed Critical Aspen Diagnostics Corp
Publication of IL91639A0 publication Critical patent/IL91639A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL91639A 1988-09-15 1989-09-14 Method for determining preeclampsia,pregnancy induced hypertension or eclampsia,a reagent and kit for use therewith IL91639A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24497088A 1988-09-15 1988-09-15
US07/302,854 US5079171A (en) 1988-09-15 1989-01-27 Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin

Publications (1)

Publication Number Publication Date
IL91639A0 true IL91639A0 (en) 1990-04-29

Family

ID=26936926

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91639A IL91639A0 (en) 1988-09-15 1989-09-14 Method for determining preeclampsia,pregnancy induced hypertension or eclampsia,a reagent and kit for use therewith

Country Status (10)

Country Link
US (1) US5079171A (el)
EP (1) EP0359274B1 (el)
JP (1) JP2597013B2 (el)
AT (1) ATE130437T1 (el)
AU (1) AU623678B2 (el)
CA (1) CA1338899C (el)
DE (1) DE68924818T2 (el)
ES (1) ES2079366T3 (el)
GR (1) GR3018101T3 (el)
IL (1) IL91639A0 (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892197A (fi) * 1989-05-08 1990-11-09 Locus Oy Foerfarande foer detektering av tumoerer.
WO1991016633A1 (en) * 1990-04-12 1991-10-31 Adeza Biomedical Corporation Pregnancy induced hypertension and eclampsia immunoassay and reagents
EP0580859A4 (en) * 1991-03-26 1994-09-14 Otsuka Pharma Co Ltd Anti-eda monoclonal antibody
DE69323131T2 (de) * 1992-03-10 1999-09-16 La Jolla Cancer Research Foundation, La Jolla Rekombinierte alkalische phosphatase aus kälberdarm
US5543138A (en) * 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
WO1996004558A1 (fr) * 1994-07-29 1996-02-15 Iatron Laboratories, Inc. Systeme de mesure fonctionnant avec du sang entier
US5849474A (en) * 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
DE19631192C2 (de) * 1996-08-03 1998-09-10 Hellmut Dr Augustin Verfahren zur Früherkennung gestosegefährdeter schwangerer Frauen
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6284194B1 (en) 1998-03-11 2001-09-04 Albert E. Chu Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity
USD432244S (en) * 1998-04-20 2000-10-17 Adeza Biomedical Corporation Device for encasing an assay test strip
USD434153S (en) * 1998-04-20 2000-11-21 Adeza Biomedical Corporation Point of care analyte detector system
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
US6642055B1 (en) 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
CA2515012A1 (en) * 2003-02-04 2004-08-26 The Administrators Of The Tulane Educational Fund Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
ATE553378T1 (de) 2003-02-06 2012-04-15 Hologic Inc Screening und behandlungsverfahren zur vorbeugung von frühgeburten
US7634360B2 (en) * 2003-09-23 2009-12-15 Prediction Sciences, LL Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US7392140B2 (en) * 2003-09-23 2008-06-24 Prediction Sciences, Llc Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US20080010024A1 (en) * 2003-09-23 2008-01-10 Prediction Sciences Llp Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
ATE534750T1 (de) * 2004-07-30 2011-12-15 Adeza Biomedical Corp Onkofetales fibronektin als zervixkarzinom-marker
WO2007053161A2 (en) 2004-12-15 2007-05-10 Beth Israel Deaconess Medical Center Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy
CN101616927A (zh) * 2005-09-15 2009-12-30 迪爱麦有限公司 诊断先兆子痫的方法
NZ578077A (en) 2007-02-12 2012-04-27 Stefan Hansson Diagnosis of preeclampsia using free foetal haemoglobin
US20100016173A1 (en) * 2008-01-30 2010-01-21 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
NZ602733A (en) 2010-03-24 2014-03-28 Preelumina Diagnostics Ab Hbf and a1m as early stage markers for preeclampsia
BR112013007311A2 (pt) 2010-10-01 2016-07-05 Hologic Inc tira de teste de imunoensaio para uso em um sistema de diagnóstico
WO2013000992A1 (en) 2011-06-28 2013-01-03 Vitateq Biotechnology Gmbh Method for diagnosing preeclampsia
PL2836843T3 (pl) * 2012-04-13 2020-12-28 Prediction Biosciences S.A.S. Szybki test do oznaczania fibronektyny komórkowej
RU2740852C1 (ru) * 2020-07-27 2021-01-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный университет" Министерства здравоохранения Российской Федерации Способ прогнозирования преэклампсии у беременных с гестационным сахарным диабетом

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0616048B2 (ja) * 1983-10-26 1994-03-02 帝国臓器製薬株式会社 フィブロネクチンの免疫学的測定
US4980279A (en) * 1986-04-15 1990-12-25 Scripps Clinic And Research Foundation Cellular fibronectin: polypeptides, anti-polypeptide antibodies and assay methods

Also Published As

Publication number Publication date
AU4131689A (en) 1990-03-22
AU623678B2 (en) 1992-05-21
ES2079366T3 (es) 1996-01-16
JPH02115767A (ja) 1990-04-27
EP0359274B1 (en) 1995-11-15
DE68924818D1 (de) 1995-12-21
EP0359274A2 (en) 1990-03-21
EP0359274A3 (en) 1990-11-28
GR3018101T3 (en) 1996-02-29
CA1338899C (en) 1997-02-11
ATE130437T1 (de) 1995-12-15
DE68924818T2 (de) 1996-05-02
US5079171A (en) 1992-01-07
JP2597013B2 (ja) 1997-04-02

Similar Documents

Publication Publication Date Title
IL91639A0 (en) Method for determining preeclampsia,pregnancy induced hypertension or eclampsia,a reagent and kit for use therewith
TW348216B (en) Method for the determination of urinary protein and creatinine
ES2001811A6 (es) Un nuevo material y un nuevo dispositivo utiles en ensayos de fijacionen fase solida para determinar la presencia o la cantidad de un analito en una muestra de ensayo
ZA971864B (en) Assays and reagents for quantifying hBNP.
EP1575295A3 (en) Method for the determination of a container track information
NZ213959A (en) Immunoassay method for the determination of a particular protein analyte in a sample
EP0316919A3 (en) Vaginal sample test and reagents
ATE12010T1 (de) Verfahren zur bestimmung von antigen-antikoerper- reaktionen und reagens hierfuer.
AU3059499A (en) Solid-phase method for antigen and antibody determinations in bloodgroup serology, and test kit
IL85921A0 (en) Method,test system and test kit for magnetic separation of labeled reagent in an immunometric binding assay
AU2640399A (en) Method for immunochemically assaying anti-hm1.24 antibody
EP0387027A3 (en) Endometriosis diagnosis methods and reagents
US4725556A (en) Process of immunoassay of a substance in a liquid sample containing a similar substance
DE3171892D1 (en) Method for detection of oncofetal antigen, for detection of cancer, for evaluation for cancer therapy and diagnostic kit suitable for such purpose
EP0848251A3 (en) Homogeneous on-line assays using capillary electrophoresis
EP0315447A3 (en) Method of immunological measurement of human protein s and reagent and kit therefor
DE3568639D1 (en) Method for the determination of a substance capable of immunological binding
CA2140921A1 (en) Method and kit for pyridinium crosslink assay
ES2066739A1 (es) Inmunoensayo para analitos en muestras empleando agentes alquilantes.
EP0321249A3 (en) Agent for and method of diagnosis of varicella zoster virus infection
AU2898889A (en) Beta-galactosidase complementation immunoassay
GB8724549D0 (en) Immunoassay
JPS6450963A (en) Uniform immunoassay using riposome
NO179468C (no) Fremgangsmåte for å bestemme antistoff og assayreagenssett for dette
EP0290017A3 (en) Method for the quantitative determination of serum protein in body fluids and composition therefor